SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006873
Filing Date
2021-05-12
Accepted
2021-05-12 08:32:55
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q obln-20210331x10q.htm 10-Q 770485
2 EX-31.1 obln-20210331ex3110593b0.htm EX-31.1 14597
3 EX-31.2 obln-20210331ex3122a0fe1.htm EX-31.2 14623
4 EX-32.1 obln-20210331ex321db3310.htm EX-32.1 9326
  Complete submission text file 0001558370-21-006873.txt   4448542

Data Files

Seq Description Document Type Size
5 EX-101.INS obln-20210331.xml EX-101.INS 1023882
6 EX-101.SCH obln-20210331.xsd EX-101.SCH 33478
7 EX-101.CAL obln-20210331_cal.xml EX-101.CAL 43446
8 EX-101.DEF obln-20210331_def.xml EX-101.DEF 103395
9 EX-101.LAB obln-20210331_lab.xml EX-101.LAB 350561
10 EX-101.PRE obln-20210331_pre.xml EX-101.PRE 250441
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 21913585
SIC: 3841 Surgical & Medical Instruments & Apparatus